---
title: "TheWell Bioscience launches VitroPrime™ 3D Culture Plate for organoid and 3D cell culture, enabling high-resolution imaging."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275328066.md"
description: "The VitroPrime™ 3D, a cutting-edge 3D cell culture plate, has been introduced by TheWell Bioscience in Monmouth Junction, New Jersey, on February 9, 2026. This innovative design allows for consistent organoid culture, downstream processing, and detailed imaging without any disruptions. With this new technology, researchers can conduct experiments with precision and efficiency. This advancement is crucial for the field of biology, offering a unique opportunity to enhance scientific research."
datetime: "2026-02-09T13:35:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275328066.md)
  - [en](https://longbridge.com/en/news/275328066.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275328066.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275328066.md) | [繁體中文](https://longbridge.com/zh-HK/news/275328066.md)


# TheWell Bioscience launches VitroPrime™ 3D Culture Plate for organoid and 3D cell culture, enabling high-resolution imaging.

The VitroPrime™ 3D, a cutting-edge 3D cell culture plate, has been introduced by TheWell Bioscience in Monmouth Junction, New Jersey, on February 9, 2026. This innovative design allows for consistent organoid culture, downstream processing, and detailed imaging without any disruptions. With this new technology, researchers can conduct experiments with precision and efficiency. This advancement is crucial for the field of biology, offering a unique opportunity to enhance scientific research.

### Related Stocks

- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [Twist Bioscience Corporation (TWST.US)](https://longbridge.com/en/quote/TWST.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [ZIVO Bioscience, Inc. (ZIVO.US)](https://longbridge.com/en/quote/ZIVO.US.md)
- [iShares US Medical Devices ETF (IHI.US)](https://longbridge.com/en/quote/IHI.US.md)
- [Harvard Bioscience, Inc. (HBIO.US)](https://longbridge.com/en/quote/HBIO.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/en/quote/IBBQ.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [bioAffinity Launches Major Lung Cancer Detection Study](https://longbridge.com/en/news/278565253.md)
- [Twist Bioscience Corporation (NASDAQ:TWST) Given Average Recommendation of "Moderate Buy" by Brokerages](https://longbridge.com/en/news/278356775.md)
- [BUZZ-MiNK Therapeutics rises as it wins funding for child cancer cell therapy](https://longbridge.com/en/news/278530484.md)
- [iBio Highlights IBIO-610 Obesity and Cardiometabolic Potential](https://longbridge.com/en/news/278383705.md)
- [C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology | INKT Stock News](https://longbridge.com/en/news/278521475.md)